<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Pulm Med</journal-id><journal-id journal-id-type="iso-abbrev">BMC Pulm Med</journal-id><journal-title-group><journal-title>BMC Pulmonary Medicine</journal-title></journal-title-group><issn pub-type="epub">1471-2466</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25182377</article-id><article-id pub-id-type="pmc">4236758</article-id><article-id pub-id-type="publisher-id">1471-2466-14-146</article-id><article-id pub-id-type="doi">10.1186/1471-2466-14-146</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Metabolic load during strength training or NMES in individuals with COPD: results from the <italic>DICES</italic> trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Sillen</surname><given-names>Maurice JH</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>mauricesillen@ciro-horn.nl</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Franssen</surname><given-names>Frits ME</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>fritsfranssen@ciro-horn.nl</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Vaes</surname><given-names>Anouk W</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>anoukvaes@ciro-horn.nl</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Delbressine</surname><given-names>Jeannet ML</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jeannetdelbressine@ciro-horn.nl</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Wouters</surname><given-names>Emiel FM</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>e.wouters@mumc.nl</email></contrib><contrib contrib-type="author" id="A6"><name><surname>Spruit</surname><given-names>Martijn A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>martijnspruit@ciro-horn.nl</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Research &#x00026; Education, CIRO+, centre of expertise for chronic organ failure, Hornerheide 1, Horn, the Netherlands</aff><aff id="I2"><label>2</label>Department of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>2</day><month>9</month><year>2014</year></pub-date><volume>14</volume><fpage>146</fpage><lpage>146</lpage><history><date date-type="received"><day>24</day><month>4</month><year>2014</year></date><date date-type="accepted"><day>26</day><month>8</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Sillen et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Sillen et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1471-2466/14/146"/><abstract><sec><title>Background</title><p>Strength training and neuromuscular electrical stimulation (NMES) are effective training modalities for improving muscle function, exercise performance and health status in individuals with COPD. The aim of the present study was to analyze the metabolic load of these training modalities at baseline, half-way, and at the end of an eight-week interdisciplinary pulmonary rehabilitation program in a subgroup of individuals with COPD of the <bold><italic>DICES</italic></bold> trial.</p></sec><sec><title>Methods</title><p>Of 24 individuals with COPD (FEV<sub>1</sub>: 34&#x02009;&#x000b1;&#x02009;2% predicted, men: 58%, age: 66 (61&#x02013;68) years), peak oxygen uptake (VO<sub>2</sub>), peak minute ventilation (V<sub>E</sub>), heart rate, oxygen saturation and symptom scores were assessed during HF-NMES (75&#x000a0;Hz), LF-NMES (15&#x000a0;Hz) and strength training at three moments during their pulmonary rehabilitation program.</p></sec><sec><title>Results</title><p>Intervention-related peak VO<sub>2</sub> did not change over time during HF-NMES, LF-NMES or strength training. Intervention-related peak V<sub>E</sub> did not change over time during strength training or LF-NMES and increased slightly, but significantly over time during HF-NMES. Peak VO<sub>2</sub> and V<sub>E</sub> were significantly higher during strength training compared to HF-NMES or LF-NMES. Oxygen saturation significantly decreased after the first measurements during HF-NMES and strength training group to baseline, while no significant changes in oxygen saturation were observed during the other measurements. Heart rate significantly increased compared to baseline in all groups at all moments and was significantly higher after strength training compared to HF-NMES or LF-NMES. Median end scores (points) for dyspnea, fatigue and muscle pain ranged from 1 to 3, from 0.5 to 2 and from 0 to 6 after HF-NMES, from 2 to 3, from 2 to 5 and from 0 to 9 after LF-NMES and from 2 to 5, from 1.5 to 4 and from 0 to 28 after strength training respectively.</p></sec><sec><title>Conclusions</title><p>To conclude, the metabolic load and symptom scores remain acceptable low over time with increasing training loads during HF-NMES, LF-NMES or strength training.</p></sec><sec><title>Trial registration</title><p><bold>Trial registration:</bold><ext-link ext-link-type="uri" xlink:href="http://www.trialregistry.nl/NTR2322">NTR2322</ext-link></p></sec></abstract><kwd-group><kwd>Chronic obstructive pulmonary disease</kwd><kwd>Neuromuscular electrical stimulation</kwd><kwd>Pulmonary rehabilitation</kwd><kwd>Strength training</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Individuals with chronic obstructive pulmonary disease (COPD) may suffer from lower-limb muscle weakness and poor exercise capacity, in particular those with severe to very severe dyspnea [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. This is most probably due to reductions in weight-bearing daily physical activities [<xref ref-type="bibr" rid="B4">4</xref>]. Therefore, an exercise-based pulmonary rehabilitation program may be beneficial [<xref ref-type="bibr" rid="B5">5</xref>]. Severely dyspneic individuals with COPD (i.e., modified MRC dyspnea grade 3 or 4), however, are less likely to complete a pulmonary rehabilitation program [<xref ref-type="bibr" rid="B6">6</xref>]. This may be due to exercise-induced dyspnea, particularly during whole-body endurance training [<xref ref-type="bibr" rid="B7">7</xref>]. Therefore, strength training [<xref ref-type="bibr" rid="B8">8</xref>] or transcutaneous neuromuscular electrical stimulation (NMES) [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>] may be preferential alternative rehabilitative modalities for severely dyspneic individuals with COPD [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. These interventions are safe and effective in severely dyspneic individuals with COPD and quadriceps muscle weakness at baseline [<xref ref-type="bibr" rid="B13">13</xref>]. Indeed, lower-limb muscle function, functional exercise performance, problematic activities of daily life, mood status, and health status improved significantly following eight weeks of strength training, high-frequency (HF, 75 Hertz) NMES, or low-frequency (LF, 15 Hertz) NMES [<xref ref-type="bibr" rid="B13">13</xref>].</p><p>A major advantage of strength training and NMES is the relatively low metabolic load (e.g., the intervention-related peak oxygen uptake (VO<sub>2</sub>) and ventilation (V<sub>E</sub>)), accompanied with relatively low dyspnea symptom scores [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. The metabolic load during multiple successive sessions of strength training has been reported once in 11 individuals with COPD [<xref ref-type="bibr" rid="B7">7</xref>]. The leg press strengthening exercise increased significantly during a 12-week pulmonary rehabilitation program (+43% of baseline training load), accompanied by a significant increase in metabolic load over time (+23% of baseline intervention-related peak VO<sub>2</sub>; +18% of baseline intervention-related peak V<sub>E</sub>) [<xref ref-type="bibr" rid="B7">7</xref>]. The metabolic load during a session of high-frequency (HF) or low-frequency (LF) NMES has only been measured cross-sectionally [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. Whether and to what extent the metabolic load will remain stable over time while the NMES pulse amplitude is expected to increase [<xref ref-type="bibr" rid="B16">16</xref>] remains currently unknown in individuals with COPD. Moreover, the actual course of NMES pulse amplitude has never been described in individuals with COPD. This, however, will provide a better insight in the feasibility and efficacy of these types of local muscle training.</p><p>The aim of the present study was to analyze the metabolic load of the different local muscle training modalities at baseline, half-way, and at the end of the eight-week program in a subgroup of individuals with COPD who participated in the <bold><italic>DICES</italic></bold> (<bold><italic>D</italic></bold>yspneic <bold><italic>I</italic></bold>ndividuals with <bold><italic>C</italic></bold>OPD: <bold><italic>E</italic></bold>lectrical stimulation or <bold><italic>S</italic></bold>trength training) trial. <italic>A priori</italic>, we hypothesized that individuals with COPD are able to increase the strength training load or NMES pulse amplitude (irrespective of stimulation frequency), while the metabolic load will remain stable compared to baseline.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Participants</title><p>In the <bold><italic>DICES</italic></bold> trial, individuals with COPD with mMRC dyspnea grade 3 or 4 [<xref ref-type="bibr" rid="B2">2</xref>], and quadriceps weakness [<xref ref-type="bibr" rid="B17">17</xref>] were randomly assigned to lower-limb HF-NMES (75 Hertz), lower-limb LF-NMES (15 Hertz), or lower-limb strength training (leg extension strengthening exercise, and leg press strengthening exercise [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B18">18</xref>]). These interventions took place in group sessions, twice per day, 5 times per week for 8&#x000a0;weeks. All sessions were supervised by a physiotherapist. The interdisciplinary treatment was identical for all participants, and treadmill walking or stationary ergometry cycling was not applied during the trial. Symptom scores for dyspnea, fatigue, and muscle pain were assessed before and after each session [<xref ref-type="bibr" rid="B19">19</xref>].</p><p>The Medical Ethical Committee of the Maastricht University Medical Centre&#x02009;+&#x02009;(MEC 09-3-072) approved this trial, which conformed to the principles outlined in the World Medical Association declaration of Helsinki which was revised in Seoul [<xref ref-type="bibr" rid="B20">20</xref>]. Details of the trial were registered at <ext-link ext-link-type="uri" xlink:href="http://www.trialregister.nl">http://www.trialregister.nl</ext-link> NTR2322) before first subject enrolment. All patients gave written informed consent to participate in the study and a subgroup additionally gave written informed consent to undergo the measurements of the metabolic load. Some of the baseline findings, and the efficacy data of the <bold><italic>DICES</italic></bold> trial have been published before [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>].</p><sec><title>Interventions</title><p>Please, <italic>see</italic> Additional file <xref ref-type="supplementary-material" rid="S1">1</xref> for all details.</p></sec><sec><title>Outcomes</title><p>Outcome assessors were blinded for treatment allocation. The investigators supervising the interventions (MJHS, AWV) were blinded for the initial results, and were not involved in the outcome assessment. Participants were instructed to not divulge their group allocation. Participants, who were randomly assigned to one of the NMES groups, were blinded for the type of stimulation frequency.</p></sec></sec><sec><title>Quadriceps muscle function</title><p>Quadriceps muscle function (i.e., peak muscle strength and muscle endurance), using a Biodex (Biodex System 4 Pro, Biodex Medical Systems, Inc., New York, USA). Quadriceps peak muscle strength (Newton-meter, Nm) and quadriceps muscle endurance (Joules, J) were measured isokinetically. The participants performed thirty volitional maximal contractions at an angular velocity of 90&#x000b0; per second. <italic>See</italic> Additional file <xref ref-type="supplementary-material" rid="S1">1</xref> for all details concerning the interventions.</p></sec><sec><title>Functional exercise performance</title><p>Functional exercise performance was measured with the 6-min walk test, including a practice walk at initial assessment [<xref ref-type="bibr" rid="B23">23</xref>]. The best 6-min walk distance (6MWD) was used for further analyses. The constant work-rate cycling endurance test (CWRT, expressed in seconds) was performed at 75% of the pre-determined peak cycling rate, which has a high reliability in individuals with COPD [<xref ref-type="bibr" rid="B24">24</xref>]. Symptom scores for exercise-induced dyspnea and fatigue were assessed before and after these exercise tests.</p></sec><sec><title>Metabolic load</title><p>Continuous on-line calculations of breath-by-breath oxygen uptake (VO<sub>2</sub>) and minute ventilation (V<sub>E</sub>), heart rate and oxygen saturation were obtained using the Oxycon mobile, a portable metabolic system (Carefusion the Netherlands, Houten, the Netherlands). The metabolic load was measured during sessions of HF-NMES, LF-NMES, or strength training in the first week, the fourth week, and in the last week of the trial. This methodology has been used before in individuals with COPD [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. <italic>See</italic> Additional file <xref ref-type="supplementary-material" rid="S1">1</xref> for all details concerning the measurement of the metabolic load.</p></sec><sec><title>Statistical analysis</title><p>Analyses were performed using SPSS for Windows, Version 17.0.1 (SPSS, Inc., Chicago, Il, USA). Descriptive statistics were presented as median and interquartile range unless otherwise stated. Differences within groups were analyzed using Wilcoxon signed rank test. Groups were compared using Mann&#x02013;Whitney U test or Kruskal-Wallis one-way analysis of variance. All tests were two-sided using a significance level of 5%.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Baseline characteristics</title><p>Of the 120 individuals who participated in the <bold><italic>DICES</italic></bold> trial, 61 individuals (51%) were ineligible for the additional metabolic data collection due to the use of long-term oxygen therapy. Moreover, 26 individuals (22%) did not consent to this extra set of tests and 3 individuals (2%) who gave informed consent withdrew before start. At baseline, from 30 individuals (25%) intervention-related peak VO<sub>2</sub>, VE, heart rate and oxygen saturation were obtained. From 24 individuals the metabolic load was measured during a session of HF-NMES (n&#x02009;=&#x02009;9), LF-NMES (n&#x02009;=&#x02009;7), or strength training (n&#x02009;=&#x02009;8) in the first week, the fourth week, and in the last week of the trial (Figure&#x000a0;<xref ref-type="fig" rid="F1">1</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Flow diagram of measurements metabolic load.</p></caption><graphic xlink:href="1471-2466-14-146-1"/></fig><p>The 24 individuals of this pre-specified sub-analysis had severe to very severe COPD, a poor diffusing capacity for carbon monoxide and a poor functional and peak exercise performance (Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>). Besides age and the relative peak ventilation during the cardiopulmonary exercise test, baseline characteristics did not significantly differ between intervention groups (Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>). Mean FEV<sub>1</sub> (34&#x02009;&#x000b1;&#x02009;2% versus 31&#x02009;&#x000b1;&#x02009;1% pred), PaCO2 (5.2&#x02009;&#x000b1;&#x02009;0.1 kPa versus 5.8&#x02009;&#x000b1;&#x02009;0.1 kPa), fat-free mass index (17.2&#x02009;&#x000b1;&#x02009;0.4&#x000a0;kg/m<sup>2</sup> versus 16.3&#x02009;&#x000b1;&#x02009;0.2&#x000a0;kg/m<sup>2</sup>) and total work (1389&#x02009;&#x000b1;&#x02009;95&#x000a0;J versus 1122&#x02009;&#x000b1;&#x02009;49&#x000a0;J) were significantly higher in the metabolic load group compared to the remaining group, other baseline characteristics (age, DLco, residual volume, PaO<sub>2</sub>, SO<sub>2</sub>, peak and functional exercise performance, body mass index, peak torque, HADS anxiety and depression and health status) were not significantly different between both groups (Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>: Table S1).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>General characteristics</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th rowspan="2" align="left" valign="top">&#x000a0;</th><th align="left" valign="bottom"><bold>Total group</bold><hr/></th><th align="left" valign="bottom"><bold>HF-NMES</bold><hr/></th><th align="left" valign="bottom"><bold>LF-NMES</bold><hr/></th><th align="left" valign="bottom"><bold>Strength training</bold><hr/></th><th rowspan="2" align="left" valign="top"><bold>P-value</bold></th></tr><tr><th align="left"><bold>n&#x02009;=&#x02009;24</bold></th><th align="left"><bold>n&#x02009;=&#x02009;9</bold></th><th align="left"><bold>n&#x02009;=&#x02009;7</bold></th><th align="left"><bold>n&#x02009;=&#x02009;8</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom">Sex (M/F)<hr/></td><td align="left" valign="bottom">14/10<hr/></td><td align="left" valign="bottom">6/3<hr/></td><td align="left" valign="bottom">4/173<hr/></td><td align="left" valign="bottom">4/4<hr/></td><td align="left" valign="bottom">0.791<hr/></td></tr><tr><td align="left" valign="bottom">Age (years)<hr/></td><td align="left" valign="bottom">66 (61&#x02013;68)<hr/></td><td align="left" valign="bottom">64 (59&#x02013;67)<hr/></td><td align="left" valign="bottom">62 (59&#x02013;67)<hr/></td><td align="left" valign="bottom">71 (66&#x02013;77)<hr/></td><td align="left" valign="bottom">0.012<hr/></td></tr><tr><td colspan="6" align="left" valign="bottom">Pulmonary function<hr/></td></tr><tr><td align="left" valign="bottom">FEV<sub>1</sub> (liters )<hr/></td><td align="left" valign="bottom">0.98 (0.78-1.05)<hr/></td><td align="left" valign="bottom">1.01 (0.84-1.19)<hr/></td><td align="left" valign="bottom">0.74 (0.60-0.84)<hr/></td><td align="left" valign="bottom">1.00 (0.96-1.10)<hr/></td><td align="left" valign="bottom">0.010<hr/></td></tr><tr><td align="left" valign="bottom">FEV<sub>1</sub> (% predicted)<hr/></td><td align="left" valign="bottom">35 (29&#x02013;51)<hr/></td><td align="left" valign="bottom">34 (23&#x02013;51)<hr/></td><td align="left" valign="bottom">30 (20&#x02013;38)<hr/></td><td align="left" valign="bottom">46 (43&#x02013;60)<hr/></td><td align="left" valign="bottom">0.064<hr/></td></tr><tr><td align="left" valign="bottom">FEV<sub>1</sub>/VC max (%)<hr/></td><td align="left" valign="bottom">32 (24&#x02013;43)<hr/></td><td align="left" valign="bottom">31 (24&#x02013;41)<hr/></td><td align="left" valign="bottom">25 (24&#x02013;29)<hr/></td><td align="left" valign="bottom">42 (33&#x02013;52)<hr/></td><td align="left" valign="bottom">0.057<hr/></td></tr><tr><td align="left" valign="bottom">DL<sub>CO</sub> (%)<hr/></td><td align="left" valign="bottom">42 (36&#x02013;55)<hr/></td><td align="left" valign="bottom">41 (31&#x02013;55)<hr/></td><td align="left" valign="bottom">42 (34&#x02013;61)<hr/></td><td align="left" valign="bottom">46 (40&#x02013;56)<hr/></td><td align="left" valign="bottom">0.802<hr/></td></tr><tr><td align="left" valign="bottom">RV (%)<hr/></td><td align="left" valign="bottom">177 (136&#x02013;235)<hr/></td><td align="left" valign="bottom">190 (137&#x02013;243)<hr/></td><td align="left" valign="bottom">208 (172&#x02013;260)<hr/></td><td align="left" valign="bottom">146 (128&#x02013;178)<hr/></td><td align="left" valign="bottom">0.081<hr/></td></tr><tr><td colspan="2" align="left" valign="bottom">Arterial blood gases<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">PaO<sub>2</sub> (kPa)<hr/></td><td align="left" valign="bottom">9.8 (8.8-10.8)<hr/></td><td align="left" valign="bottom">9.0 (8.5-10.9)<hr/></td><td align="left" valign="bottom">9.6 (8.5-9.9)<hr/></td><td align="left" valign="bottom">10.3 (9.4-11.2)<hr/></td><td align="left" valign="bottom">0.284<hr/></td></tr><tr><td align="left" valign="bottom">PaCO<sub>2</sub> (kPa)<hr/></td><td align="left" valign="bottom">4.9 (4.7-5.5)<hr/></td><td align="left" valign="bottom">5.4 (4.8-5.7)<hr/></td><td align="left" valign="bottom">5.0 (4.7-5.6)<hr/></td><td align="left" valign="bottom">4.8 (4.6-5.1)<hr/></td><td align="left" valign="bottom">0.159<hr/></td></tr><tr><td align="left" valign="bottom">SaO<sub>2</sub> (%)<hr/></td><td align="left" valign="bottom">96 (95&#x02013;97)<hr/></td><td align="left" valign="bottom">95 (95&#x02013;97)<hr/></td><td align="left" valign="bottom">95 (94&#x02013;97)<hr/></td><td align="left" valign="bottom">97 (96&#x02013;98)<hr/></td><td align="left" valign="bottom">0.166<hr/></td></tr><tr><td align="left" valign="bottom">GOLD classification (I/II/III/IV)<hr/></td><td align="left" valign="bottom">0/7/10/7<hr/></td><td align="left" valign="bottom">0/3/3/3<hr/></td><td align="left" valign="bottom">0/0/4/3<hr/></td><td align="left" valign="bottom">0/4/3/1<hr/></td><td align="left" valign="bottom">0.025<hr/></td></tr><tr><td align="left" valign="bottom">GOLD classification (new) (A/B/C/D)<hr/></td><td align="left" valign="bottom">0/3/0/21<hr/></td><td align="left" valign="bottom">0/2/0/7<hr/></td><td align="left" valign="bottom">0/0/0/7<hr/></td><td align="left" valign="bottom">0/1/0/7<hr/></td><td align="left" valign="bottom">0.427<hr/></td></tr><tr><td align="left" valign="bottom">BMI (kg/m<sup>2</sup>)<hr/></td><td align="left" valign="bottom">25.4 (22.2-29.8)<hr/></td><td align="left" valign="bottom">25.4 (21.9-26.9)<hr/></td><td align="left" valign="bottom">24.6 (23.5-30.3)<hr/></td><td align="left" valign="bottom">26.9 (21.5-31.1)<hr/></td><td align="left" valign="bottom">0.834<hr/></td></tr><tr><td align="left" valign="bottom">FFMI (kg/m<sup>2</sup>)<hr/></td><td align="left" valign="bottom">17.0 (15.8-18.5)<hr/></td><td align="left" valign="bottom">16.9 (15.7-17.5)<hr/></td><td align="left" valign="bottom">16.5 (15.7-18.8)<hr/></td><td align="left" valign="bottom">17.4 (15.8-19.1)<hr/></td><td align="left" valign="bottom">0.680<hr/></td></tr><tr><td colspan="6" align="left" valign="bottom">Cardiopulmonary exercise test<hr/></td></tr><tr><td align="left" valign="bottom">Peak load (watts)<hr/></td><td align="left" valign="bottom">47 (35&#x02013;57)<hr/></td><td align="left" valign="bottom">51 (35&#x02013;57)<hr/></td><td align="left" valign="bottom">46 (41&#x02013;62)<hr/></td><td align="left" valign="bottom">44 (30&#x02013;58)<hr/></td><td align="left" valign="bottom">0.867<hr/></td></tr><tr><td align="left" valign="bottom">Peak load (% predicted)<hr/></td><td align="left" valign="bottom">33 (23&#x02013;47)<hr/></td><td align="left" valign="bottom">26 (23&#x02013;39)<hr/></td><td align="left" valign="bottom">38 (22&#x02013;81)<hr/></td><td align="left" valign="bottom">39 (23&#x02013;63)<hr/></td><td align="left" valign="bottom">0.481<hr/></td></tr><tr><td align="left" valign="bottom">Peak VO<sub>2</sub> ( ml/min)<hr/></td><td align="left" valign="bottom">841 (710&#x02013;987)<hr/></td><td align="left" valign="bottom">751 (697&#x02013;919)<hr/></td><td align="left" valign="bottom">817 (734&#x02013;1087)<hr/></td><td align="left" valign="bottom">904 (699&#x02013;1076)<hr/></td><td align="left" valign="bottom">0.473<hr/></td></tr><tr><td align="left" valign="bottom">Peak VO<sub>2</sub> (% predicted)<hr/></td><td align="left" valign="bottom">48 (33&#x02013;73)<hr/></td><td align="left" valign="bottom">31 (27&#x02013;64)<hr/></td><td align="left" valign="bottom">53 (40&#x02013;90)<hr/></td><td align="left" valign="bottom">52 (40&#x02013;115)<hr/></td><td align="left" valign="bottom">0.142<hr/></td></tr><tr><td align="left" valign="bottom">Peak VE (liters)<hr/></td><td align="left" valign="bottom">33 (29&#x02013;39)<hr/></td><td align="left" valign="bottom">38 (28&#x02013;41)<hr/></td><td align="left" valign="bottom">32 (25&#x02013;35)<hr/></td><td align="left" valign="bottom">35 (29&#x02013;44)<hr/></td><td align="left" valign="bottom">0.553<hr/></td></tr><tr><td align="left" valign="bottom">Peak VE (% MVV)<hr/></td><td align="left" valign="bottom">89 (78&#x02013;107)<hr/></td><td align="left" valign="bottom">84 (72&#x02013;98)<hr/></td><td align="left" valign="bottom">103 (95&#x02013;119)<hr/></td><td align="left" valign="bottom">81 (68&#x02013;101)<hr/></td><td align="left" valign="bottom">0.040<hr/></td></tr><tr><td align="left" valign="bottom">Peak HR (bpm)<hr/></td><td align="left" valign="bottom">104 (98&#x02013;124)<hr/></td><td align="left" valign="bottom">103 (98&#x02013;122)<hr/></td><td align="left" valign="bottom">126 (104&#x02013;131)<hr/></td><td align="left" valign="bottom">102 (90&#x02013;109)<hr/></td><td align="left" valign="bottom">0.080<hr/></td></tr><tr><td align="left" valign="bottom">Peak HR (% predicted)<hr/></td><td align="left" valign="bottom">71 (64&#x02013;75)<hr/></td><td align="left" valign="bottom">66 (64&#x02013;73)<hr/></td><td align="left" valign="bottom">75 (68&#x02013;83)<hr/></td><td align="left" valign="bottom">70 (63&#x02013;72)<hr/></td><td align="left" valign="bottom">0.186<hr/></td></tr><tr><td align="left" valign="bottom">Dyspnea, end (points)<hr/></td><td align="left" valign="bottom">7 (5&#x02013;8)<hr/></td><td align="left" valign="bottom">7 (5&#x02013;7.5)<hr/></td><td align="left" valign="bottom">7 (7&#x02013;9)<hr/></td><td align="left" valign="bottom">8 (5&#x02013;9.5)<hr/></td><td align="left" valign="bottom">0.526<hr/></td></tr><tr><td align="left" valign="bottom">Fatigue, end (points)<hr/></td><td align="left" valign="bottom">5 (3&#x02013;7)<hr/></td><td align="left" valign="bottom">5 (3.5-7.5)<hr/></td><td align="left" valign="bottom">5 (3&#x02013;7)<hr/></td><td align="left" valign="bottom">4 (3&#x02013;7)<hr/></td><td align="left" valign="bottom">0.861<hr/></td></tr><tr><td align="left">Saturation, end (%)</td><td align="left">91 (89&#x02013;95)</td><td align="left">93 (91&#x02013;98)</td><td align="left">90 (89&#x02013;91)</td><td align="left">94 (89&#x02013;96)</td><td align="left">0.132</td></tr></tbody></table><table-wrap-foot><p>Values expressed as median (interquartile range) or numbers. Data are compared between HF-NMES, LF-NMES and strength training.</p><p><italic>Abbreviations:</italic> HF-NMES&#x02009;=&#x02009;High-frequency transcutaneous neuromuscular electrical stimulation; LF-NMES&#x02009;=&#x02009;Low-frequency transcutaneous neuromuscular electrical stimulation; M&#x02009;=&#x02009;males; F&#x02009;=&#x02009;females; FEV<sub>1</sub>&#x02009;=&#x02009;forced expiratory volume in one second; VC max&#x02009;=&#x02009;maximum vital capacity; DL<sub>CO</sub>&#x02009;=&#x02009;diffusion capacity of the lung for carbon monoxide; RV&#x02009;=&#x02009;residual volume; PaO2&#x02009;=&#x02009;resting arterial oxygen tension; PaCO2&#x02009;=&#x02009;resting arterial carbon dioxide tension; SaO2&#x02009;=&#x02009;resting arterial oxygen tension; kPa&#x02009;=&#x02009;kilopascal; LTOT&#x02009;=&#x02009;long-term oxygen therapy; GOLD&#x02009;=&#x02009;Global Initiative on Obstructive Lung Diseases; BMI&#x02009;=&#x02009;body mass index; FFMI&#x02009;=&#x02009;fat free mass index; kg/m<sup>2</sup>&#x02009;=&#x02009;kilogram per square meter; VO<sub>2</sub>&#x02009;=&#x02009;oxygen uptake; tSaO<sub>2</sub>&#x02009;=&#x02009;transcutaneous oxygen saturation; ml/min&#x02009;=&#x02009;milliliters per minute; % MVV&#x02009;=&#x02009;percentage maximal voluntary ventilation; bpm&#x02009;=&#x02009;beats per minute.</p></table-wrap-foot></table-wrap></sec><sec><title>Efficacy of interventions</title><sec><title>Quadriceps muscle strength</title><p>Isokinetic quadriceps peak torque increased significantly following HF-NMES (12.6&#x000a0;Nm (3.0-17.5&#x000a0;Nm); p&#x02009;=&#x02009;0.021), but not following LF-NMES (4.2&#x000a0;Nm (&#x02212;5.2-5&#x000a0;Nm); p&#x02009;=&#x02009;0.866) or strength training (5.7&#x000a0;Nm (&#x02212;9-22&#x000a0;Nm); p&#x02009;=&#x02009;0.263) (Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>). There were no significant between-group differences in changes.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>Individual changes in quadriceps peak torque and total work from baseline to end.</bold> Abbreviations: HF-NMES=high-frequency transcutaneous neuromuscular electrical stimulation; LF-NMES=low-frequency transcutaneous neuromuscular electrical stimulation (quadriceps peak torque: <bold>A, B</bold> and <bold>C</bold>; quadriceps muscle endurance: <bold>D, E</bold> and <bold>F</bold>). The bold line represents the median values.</p></caption><graphic xlink:href="1471-2466-14-146-2"/></fig></sec><sec><title>Quadriceps muscle endurance</title><p>Isokinetic total work increased significantly following HF-NMES (292&#x000a0;J (156&#x02013;501&#x000a0;J); p&#x02009;&#x0003c;&#x02009;0.01), but not following LF-NMES (12&#x000a0;J (&#x02212;73-178&#x000a0;J); p&#x02009;=&#x02009;0.499) or strength training (157&#x000a0;J (&#x02212;185-456&#x000a0;J); p&#x02009;=&#x02009;0.263) (Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>). The improvement following HF-NMES was significantly higher compared to LF-NMES (p&#x02009;=&#x02009;0.005) (Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>).</p></sec><sec><title>Six-minute walk distance</title><p>6MWD improved significantly following HF-NMES (75&#x000a0;m (29&#x02013;138&#x000a0;m); p&#x02009;=&#x02009;0.008) or strength training (57&#x000a0;m (32&#x02013;85&#x000a0;m); p&#x02009;=&#x02009;0.034), but not following LF-NMES (27&#x000a0;m (&#x02212;34-65&#x000a0;m); p&#x02009;=&#x02009;0.310). There were no significant differences in changes between groups.</p></sec><sec><title>Constant work-rate test</title><p>Endurance time during the constant work-rate cycling test improved significantly following HF-NMES (92&#x000a0;s (49&#x02013;275&#x000a0;s); p&#x02009;=&#x02009;0.066), LF-NMES (83&#x000a0;s (&#x02212;7-223&#x000a0;s); p&#x02009;=&#x02009;0.091) or strength training (37&#x000a0;s (1&#x02013;98&#x000a0;s); p&#x02009;=&#x02009;0.043). There were no significant differences in changes between groups.</p></sec></sec><sec><title>Course of HF-NMES, LF-NMES or strength training</title><p>In the HF-NMES group, pulse amplitude ranged from 12 to 40&#x000a0;mA in week one to 34 to 71&#x000a0;mA in week eight (p&#x02009;=&#x02009;0.008); and in the LF-NMES group from 25 to 50&#x000a0;mA to 35 to 98&#x000a0;mA (p&#x02009;=&#x02009;0.063, Figure&#x000a0;<xref ref-type="fig" rid="F3">3</xref>). Median end dyspnea scores, end fatigue scores and end muscle pain scores ranged from 1 to 3 points, from 0.5 to 2 points and from 0 to 6 points in the HF-NMES group and from 2 to 3 points, from 2 to 5 points and from 0 to 9 points in the LF-NMES group respectively. The load during leg extension strengthening exercise ranged from 2.5 to 20&#x000a0;kg in week one to 12.5 to 27.5&#x000a0;kg in week eight; and from 5 to 70&#x000a0;kg to 35 to 90&#x000a0;kg for the leg press strengthening exercise (both p&#x02009;&#x0003c;&#x02009;0.02, Figure&#x000a0;<xref ref-type="fig" rid="F3">3</xref>). In addition, median end dyspnea scores, end fatigue scores and end muscle pain scores ranged from 2 to 5 points, from 1.5 to 4 points and from 0 to 28 points in the strength training group.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Course in pulse amplitude and training load during the rehabilitation program.</bold> Course in pulse amplitude is shown during HF-NMES <bold>(A)</bold> and LF-NMES <bold>(B)</bold>. Course in training load is shown during leg extension exercise <bold>(C)</bold> and leg press <bold>(D)</bold>. Data are shown as median and interquartile range. Abbreviations: HF-NMES=high-frequency transcutaneous neuromuscular electrical stimulation; LF-NMES=low-frequency transcutaneous neuromuscular electrical stimulation.</p></caption><graphic xlink:href="1471-2466-14-146-3"/></fig></sec><sec><title>Metabolic load during HF-NMES, LF-NMES or strength training</title><p>Intervention-related peak VO<sub>2</sub> did not change over time all three interventions (Figure&#x000a0;<xref ref-type="fig" rid="F4">4</xref>A, Table&#x000a0;<xref ref-type="table" rid="T2">2</xref>). Intervention-related peak V<sub>E</sub> did not change over time in the strength training or LF-NMES group (p&#x02009;&#x0003e;&#x02009;0.171). In the HF-NMES group, the intervention-related V<sub>E</sub> increased slightly, but significantly over time (p&#x02009;=&#x02009;0.012, Figure&#x000a0;<xref ref-type="fig" rid="F4">4</xref>B). At all measurement points, intervention-related peak VO<sub>2</sub> and V<sub>E</sub> were significantly higher during strength training sessions compared to the HF-NMES or LF-NMES sessions (all p&#x02009;&#x0003c;&#x02009;0.05). There were no differences between HF-NMES and LF-NMES (p&#x02009;&#x0003e;&#x02009;0.28). Oxygen saturation (lowest values) was significant lower at the end of the fist measurements in the HF-NMES group and the strength training group compared with baseline (both p&#x02009;&#x0003c;&#x02009;0.03), during the other measurements no significant changes in oxygen saturation were observed (all p&#x02009;&#x0003e;&#x02009;0.05) (Table&#x000a0;<xref ref-type="table" rid="T3">3</xref>). There were no significant between-group differences in changes in oxygen saturation (all p&#x02009;&#x0003e;&#x02009;0.05). Heart rate was significantly higher at the end compared to baseline in all groups in all measurements (p&#x02009;&#x0003c;&#x02009;0.05) (Table&#x000a0;<xref ref-type="table" rid="T3">3</xref>). During all measurements, changes in heart rate were significantly higher after strength training compared to HF-NMES or LF-NMES (p&#x02009;&#x0003c;&#x02009;0.04).</p><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>Course in VO</bold><sub><bold>2 </bold></sub><bold>and ventilation during HF-NMES, LF-NMES and strength training.</bold> Course in VO<sub>2</sub> is shown in <bold>A</bold> and course in ventilation (VE) is shown in <bold>B</bold>. Data are shown as median and interquartile range. Abbreviations: HF-NMES=high-frequency transcutaneous neuromuscular electrical stimulation; LF-NMES=low-frequency transcutaneous neuromuscular electrical stimulation; VO<sub>2</sub>=oxygen uptake. *p&#x0003c;0.05.</p></caption><graphic xlink:href="1471-2466-14-146-4"/></fig><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Oxygen uptake and ventilation during HF-NMES, LF-NMES or strength training</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th rowspan="2" colspan="2" align="left" valign="top">&#x000a0;</th><th align="center" valign="bottom"><bold>HF-NMES</bold><hr/></th><th align="center" valign="bottom"><bold>LF-NMES</bold><hr/></th><th align="center" valign="bottom"><bold>Strength training</bold><hr/></th></tr><tr><th align="center"><bold>n&#x02009;=&#x02009;9</bold></th><th align="center"><bold>n&#x02009;=&#x02009;8</bold></th><th align="center"><bold>n&#x02009;=&#x02009;7</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom">VO<sub>2</sub><hr/></td><td align="left" valign="bottom">ml/min<hr/></td><td align="center" valign="bottom">424 (312&#x02013;438)<hr/></td><td align="center" valign="bottom">369 (323&#x02013;512)<hr/></td><td align="center" valign="bottom">630 (593&#x02013;759)<hr/></td></tr><tr><td align="left" valign="bottom">VE<hr/></td><td align="left" valign="bottom">L/min<hr/></td><td align="center" valign="bottom">19 (15&#x02013;22)<hr/></td><td align="center" valign="bottom">20 (15&#x02013;24)<hr/></td><td align="center" valign="bottom">26 (23&#x02013;33)<hr/></td></tr><tr><td align="left" valign="bottom">VO<sub>2</sub><hr/></td><td align="left" valign="bottom">ml/min<hr/></td><td align="center" valign="bottom">387 (345&#x02013;418)<hr/></td><td align="center" valign="bottom">454 (335&#x02013;530)<hr/></td><td align="center" valign="bottom">659 (576&#x02013;754)<hr/></td></tr><tr><td align="left" valign="bottom">VE<hr/></td><td align="left" valign="bottom">L/min<hr/></td><td align="center" valign="bottom">17 (16&#x02013;20)<hr/></td><td align="center" valign="bottom">21 (16&#x02013;25)<hr/></td><td align="center" valign="bottom">30 (25&#x02013;33)<hr/></td></tr><tr><td align="left" valign="bottom">VO<sub>2</sub><hr/></td><td align="left" valign="bottom">ml/min<hr/></td><td align="center" valign="bottom">438 (366&#x02013;619)<hr/></td><td align="center" valign="bottom">447 (329&#x02013;518)<hr/></td><td align="center" valign="bottom">725 (603&#x02013;861)<hr/></td></tr><tr><td align="left">VE</td><td align="left">L/min</td><td align="center">21 (17&#x02013;25)</td><td align="center">20 (15&#x02013;24)</td><td align="center">30 (27&#x02013;33)</td></tr></tbody></table><table-wrap-foot><p>Values expressed as median (interquartile range).</p><p><italic>Abbreviations:</italic> HF-NMES&#x02009;=&#x02009;high-frequency transcutaneous neuromuscular electrical stimulation; LF-NMES&#x02009;=&#x02009;low-frequency transcutaneous neuromuscular electrical stimulation; VO<sub>2</sub>&#x02009;=&#x02009;oxygen uptake; VE&#x02009;=&#x02009;ventilation; ml/min&#x02009;=&#x02009;milliliters per minute; L/min&#x02009;=&#x02009;liters per minute.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Oxygen saturation and peak heart rate during HF-NMES, LF-NMES or strength training</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th rowspan="2" colspan="2" align="left" valign="top">&#x000a0;<hr/></th><th colspan="3" align="center" valign="bottom"><bold>HF-NMES</bold><hr/></th><th colspan="3" align="center" valign="bottom"><bold>LF-NMES</bold><hr/></th><th colspan="3" align="center" valign="bottom"><bold>Strength training</bold><hr/></th></tr><tr><th colspan="3" align="center" valign="bottom"><bold>n&#x02009;=&#x02009;9</bold><hr/></th><th colspan="3" align="center" valign="bottom"><bold>n&#x02009;=&#x02009;8</bold><hr/></th><th colspan="3" align="center" valign="bottom"><bold>n&#x02009;=&#x02009;7</bold><hr/></th></tr><tr><th colspan="2" align="left">&#x000a0;</th><th align="center"><bold>Pre</bold></th><th align="center"><bold>Post</bold></th><th align="center"><bold>P-value</bold></th><th align="center"><bold>Pre</bold></th><th align="center"><bold>Post</bold></th><th align="center"><bold>P-value</bold></th><th align="center"><bold>Pre</bold></th><th align="center"><bold>Post</bold></th><th align="center"><bold>P-value</bold></th></tr></thead><tbody valign="top"><tr><td colspan="11" align="left" valign="bottom">First measurement<hr/></td></tr><tr><td align="left" valign="bottom">SpO<sub>2</sub><hr/></td><td align="left" valign="bottom">%<hr/></td><td align="center" valign="bottom">96 (92&#x02013;97)<hr/></td><td align="center" valign="bottom">93 (91&#x02013;95)<hr/></td><td align="center" valign="bottom">0.020<hr/></td><td align="center" valign="bottom">89 (86&#x02013;96)<hr/></td><td align="center" valign="bottom">88 (84&#x02013;95)<hr/></td><td align="center" valign="bottom">0.059<hr/></td><td align="center" valign="bottom">95 (89&#x02013;95)<hr/></td><td align="center" valign="bottom">91 (84&#x02013;93)<hr/></td><td align="center" valign="bottom">0.027<hr/></td></tr><tr><td align="left" valign="bottom">Heart rate<hr/></td><td align="left" valign="bottom">bpm<hr/></td><td align="center" valign="bottom">83 (77&#x02013;87)<hr/></td><td align="center" valign="bottom">92 (82&#x02013;97)<hr/></td><td align="center" valign="bottom">0.007<hr/></td><td align="center" valign="bottom">95 (80&#x02013;106)<hr/></td><td align="center" valign="bottom">100 (85&#x02013;112)<hr/></td><td align="center" valign="bottom">0.042<hr/></td><td align="center" valign="bottom">66 (60&#x02013;91)<hr/></td><td align="center" valign="bottom">86 (77&#x02013;102)<hr/></td><td align="center" valign="bottom">0.018<hr/></td></tr><tr><td colspan="11" align="left" valign="bottom">Second measurement<hr/></td></tr><tr><td align="left" valign="bottom">SpO<sub>2</sub><hr/></td><td align="left" valign="bottom">%<hr/></td><td align="center" valign="bottom">93 (88&#x02013;97)<hr/></td><td align="center" valign="bottom">91 (88&#x02013;95)<hr/></td><td align="center" valign="bottom">0.056<hr/></td><td align="center" valign="bottom">94 (92&#x02013;98)<hr/></td><td align="center" valign="bottom">92 (85&#x02013;96)<hr/></td><td align="center" valign="bottom">0.066<hr/></td><td align="center" valign="bottom">92 (90&#x02013;94)<hr/></td><td align="center" valign="bottom">88 (88&#x02013;91)<hr/></td><td align="center" valign="bottom">0.149<hr/></td></tr><tr><td align="left" valign="bottom">Heart rate<hr/></td><td align="left" valign="bottom">bpm<hr/></td><td align="center" valign="bottom">83 (78&#x02013;89)<hr/></td><td align="center" valign="bottom">91 (85&#x02013;100)<hr/></td><td align="center" valign="bottom">0.012<hr/></td><td align="center" valign="bottom">87 (85&#x02013;97)<hr/></td><td align="center" valign="bottom">100 (93&#x02013;106)<hr/></td><td align="center" valign="bottom">0.018<hr/></td><td align="center" valign="bottom">74 (58&#x02013;89)<hr/></td><td align="center" valign="bottom">93 (75&#x02013;109)<hr/></td><td align="center" valign="bottom">0.012<hr/></td></tr><tr><td colspan="11" align="left" valign="bottom">Third measurement<hr/></td></tr><tr><td align="left" valign="bottom">SpO<sub>2</sub><hr/></td><td align="left" valign="bottom">%<hr/></td><td align="center" valign="bottom">93 (89&#x02013;98)<hr/></td><td align="center" valign="bottom">93 (89&#x02013;97)<hr/></td><td align="center" valign="bottom">0.666<hr/></td><td align="center" valign="bottom">87 (85&#x02013;96)<hr/></td><td align="center" valign="bottom">92 (84&#x02013;94)<hr/></td><td align="center" valign="bottom">0.498<hr/></td><td align="center" valign="bottom">95 (91&#x02013;96)<hr/></td><td align="center" valign="bottom">91 (88&#x02013;94)<hr/></td><td align="center" valign="bottom">0.058<hr/></td></tr><tr><td align="left">Heart rate</td><td align="left">bpm</td><td align="center">82 (73&#x02013;90)</td><td align="center">91 (88&#x02013;101)</td><td align="center">0.008</td><td align="center">84 (77&#x02013;98)</td><td align="center">94 (82&#x02013;106)</td><td align="center">0.043</td><td align="center">76 (62&#x02013;93)</td><td align="center">93 (79&#x02013;109)</td><td align="center">0.018</td></tr></tbody></table><table-wrap-foot><p>Values expressed as median (interquartile range).</p><p><italic>Abbreviations:</italic> HF-NMES&#x02009;=&#x02009;high-frequency transcutaneous neuromuscular electrical stimulation; LF-NMES&#x02009;=&#x02009;low-frequency transcutaneous neuromuscular electrical stimulation; SpO<sub>2</sub>&#x02009;=&#x02009;oxygen saturation; bpm&#x02009;=&#x02009;beats per minute.</p></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>This is the first study to investigate the metabolic load of various local muscle training modalities in severely dyspneic COPD patients with quadriceps muscle weakness during the course of an inpatient pulmonary rehabilitation program. It showed that the metabolic load measured during successive sessions of strength training, HF-NMES, or LF-NMES remained generally stable, while the NMES pulse amplitude or the strength training load increased significantly during the eight-week intervention period.</p><p>The median oxygen uptake during the baseline session of HF-NMES, LF-NMES or strength training ranged between 30 and 99% of the peak aerobic capacity measured during the cardiopulmonary exercise test, and was comparable with previous studies [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. The median oxygen uptake was 99% of the peak aerobic capacity in one subject who was characterized with very severe COPD (FEV<sub>1</sub>: 17% pred) and a very decreased exercise capacity (peak load: 20% pred; VO<sub>2</sub> peak: 688&#x000a0;ml/min (26% pred)). At all measurement points, intervention-related peak VO<sub>2</sub> and V<sub>E</sub> were significantly lower during NMES (LF and HF) compared with strength training. This is in line with previous studies measuring the metabolic load in patients with COPD during NMES or strength training [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. However, these results are in contrast with the findings of a study in healthy male recreational athletes comparing one session of voluntary contractions with one session of HF-NMES (75&#x000a0;Hz) [<xref ref-type="bibr" rid="B25">25</xref>]. Theurel and colleagues found that the average oxygen consumption and ventilation were significantly higher during HF-NMES compared with voluntary exercise [<xref ref-type="bibr" rid="B25">25</xref>]. Besides the study design and subjects, an important difference with the present study is the training load [<xref ref-type="bibr" rid="B25">25</xref>]. Theurel and colleagues used an average training load in strength training of 46% of the maximal voluntary contraction instead of 60-70% of the one-repetition maximum which is used in our study and what is recommended by the American College of Sports Medicine [<xref ref-type="bibr" rid="B8">8</xref>].</p><p>The present study shows no changes over time in the metabolic load which is not in line with the study of Probst and colleagues [<xref ref-type="bibr" rid="B7">7</xref>]. Probst and colleagues showed a significant increase in oxygen uptake and ventilation during a 12 wk program of leg press exercises [<xref ref-type="bibr" rid="B7">7</xref>]. This could be attributable to a greater increase in the training load. However, the change in training load of leg press exercises was comparable to the present study.</p><p>The median increase in pulse amplitude during the study was 24&#x000a0;mA in HF-NMES and 37&#x000a0;mA in LF-NMES. The course in pulse amplitude is comparable with previous studies in severely disabled patients with COPD which respond to NMES [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. The low metabolic load accompanied with acceptable low dyspnea and fatigue scores probably explains the applicability of these interventions in severely disabled and dyspneic patients, even during acute COPD exacerbations [<xref ref-type="bibr" rid="B26">26</xref>-<xref ref-type="bibr" rid="B28">28</xref>]. This is also probably the reason that NMES can easily be applied in bed-bound individuals with chronic hypercapnic respiratory failure due to COPD who are receiving mechanical ventilation [<xref ref-type="bibr" rid="B29">29</xref>] or critically ill patients in the intensive care unit [<xref ref-type="bibr" rid="B30">30</xref>].</p><p>Because of the constant metabolic load in combination with stable symptom scores over time, it seems reasonable to hypothesize that the improvements in muscle function are at least partially due to intramuscular changes. Previously, it has been shown that type I and IIa fibers increased following LF-NMES [<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>] or HF-NMES [<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B34">34</xref>]. Strength training generally results in increased levels of glycolytic enzymes [<xref ref-type="bibr" rid="B35">35</xref>] and an increase in percentage and size of type II fibers [<xref ref-type="bibr" rid="B36">36</xref>-<xref ref-type="bibr" rid="B39">39</xref>].</p><p>Obviously, this study has some limitations. First, the inclusion criteria of the <italic>DICES</italic> trial limits the external validity of the present findings. Only COPD patients with an mMRC score of 3 and 4 in combination with muscle weakness were included. Secondly, the small sample size and selected patient characteristics for participation in the measurements with the Oxycon mobile may be an important reason for detecting no significant improvements in peak muscle strength in the strength training group and quadriceps muscle endurance in the LF-NMES group and the strength training group. Only patients without long-term oxygen therapy (LTOT) were eligible to participate due to the methodology used [<xref ref-type="bibr" rid="B7">7</xref>], although LTOT patients are also likely to have benefit from these interventions. However, the equipment (Oxycon mobile, a portable metabolic system) is not able to measure oxygen uptake (VO<sub>2</sub>) while breathing inspiratory O<sub>2</sub> fractions [<xref ref-type="bibr" rid="B7">7</xref>]. In the DICES trial 51% of the patients used LTOT [<xref ref-type="bibr" rid="B40">40</xref>]. It is unclear if the metabolic load might be different in LTOT patients. Moreover, the small sample size and the exclusion of LTOT patients may limit the external validity and broad applicability of these findings.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>To conclude, the metabolic load and symptom scores for dyspnea, fatigue and muscle pain remain acceptable low over time with increasing training loads during HF-NMES, LF-NMES or strength training. For this reason, these interventions are recommended in severely dyspneic patients with COPD for improving their muscle function and exercise performance.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors&#x02019; contributions</title><p>Study concept and design: MJHS, EFMW and MAS; acquisition of data: MJHS, JMLD, AWV; analysis and interpretation of data: MJHS, FMEF and MAS; drafting the article: MJHS, FMEF and MAS; revising it critically for important intellectual content: all authors; final approval of the version to be published: all authors. MJHS had full access to all study data and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2466/14/146/prepub">http://www.biomedcentral.com/1471-2466/14/146/prepub</ext-link></p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1</title><p>Online Supplement.</p></caption><media xlink:href="1471-2466-14-146-S1.doc"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><sec><title>Acknowledgements</title><p>The present authors are grateful to the patients who volunteered in the <italic>DICES</italic> trial. The authors also thank Martijn Cuijpers and Martyna Renckens for their valuable help. This research was supported by grants from the Lung Foundation, Leusden, the Netherlands, Grant 3.4.09.024 and the Weijerhorst Foundation, Maastricht, the Netherlands.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Seymour</surname><given-names>JM</given-names></name><name><surname>Spruit</surname><given-names>MA</given-names></name><name><surname>Hopkinson</surname><given-names>NS</given-names></name><name><surname>Natanek</surname><given-names>SA</given-names></name><name><surname>Man</surname><given-names>WD</given-names></name><name><surname>Jackson</surname><given-names>A</given-names></name><name><surname>Gosker</surname><given-names>HR</given-names></name><name><surname>Schols</surname><given-names>AM</given-names></name><name><surname>Moxham</surname><given-names>J</given-names></name><name><surname>Polkey</surname><given-names>MI</given-names></name><name><surname>Wouters</surname><given-names>EF</given-names></name><article-title>The prevalence of quadriceps weakness in COPD and the relationship with disease severity</article-title><source>Eur Respir J</source><year>2010</year><volume>36</volume><issue>1</issue><fpage>81</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1183/09031936.00104909</pub-id><pub-id pub-id-type="pmid">19897554</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Spruit</surname><given-names>MA</given-names></name><name><surname>Pennings</surname><given-names>HJ</given-names></name><name><surname>Janssen</surname><given-names>PP</given-names></name><name><surname>Does</surname><given-names>JD</given-names></name><name><surname>Scroyen</surname><given-names>S</given-names></name><name><surname>Akkermans</surname><given-names>MA</given-names></name><name><surname>Mostert</surname><given-names>R</given-names></name><name><surname>Wouters</surname><given-names>EF</given-names></name><article-title>Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade</article-title><source>Respir Med</source><year>2007</year><volume>101</volume><issue>12</issue><fpage>2454</fpage><lpage>2463</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2007.07.003</pub-id><pub-id pub-id-type="pmid">17765532</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Spruit</surname><given-names>MA</given-names></name><name><surname>Watkins</surname><given-names>ML</given-names></name><name><surname>Edwards</surname><given-names>LD</given-names></name><name><surname>Vestbo</surname><given-names>J</given-names></name><name><surname>Calverley</surname><given-names>PM</given-names></name><name><surname>Pinto-Plata</surname><given-names>V</given-names></name><name><surname>Celli</surname><given-names>BR</given-names></name><name><surname>Tal-Singer</surname><given-names>R</given-names></name><name><surname>Wouters</surname><given-names>EF</given-names></name><article-title>Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort</article-title><source>Respir Med</source><year>2010</year><volume>104</volume><issue>6</issue><fpage>849</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2009.12.007</pub-id><pub-id pub-id-type="pmid">20471236</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Waschki</surname><given-names>B</given-names></name><name><surname>Spruit</surname><given-names>MA</given-names></name><name><surname>Watz</surname><given-names>H</given-names></name><name><surname>Albert</surname><given-names>PS</given-names></name><name><surname>Shrikrishna</surname><given-names>D</given-names></name><name><surname>Groenen</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>C</given-names></name><name><surname>Man</surname><given-names>WD</given-names></name><name><surname>Tal-Singer</surname><given-names>R</given-names></name><name><surname>Edwards</surname><given-names>LD</given-names></name><name><surname>Calverley</surname><given-names>PM</given-names></name><name><surname>Magnussen</surname><given-names>H</given-names></name><name><surname>Polkey</surname><given-names>MI</given-names></name><article-title>Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study</article-title><source>Respir Med</source><year>2012</year><volume>106</volume><issue>4</issue><fpage>522</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2011.10.022</pub-id><pub-id pub-id-type="pmid">22118987</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Spruit</surname><given-names>MA</given-names></name><name><surname>Singh</surname><given-names>SJ</given-names></name><name><surname>Garvey</surname><given-names>C</given-names></name><name><surname>Zuwallack</surname><given-names>R</given-names></name><name><surname>Nici</surname><given-names>L</given-names></name><name><surname>Rochester</surname><given-names>C</given-names></name><name><surname>Hill</surname><given-names>K</given-names></name><name><surname>Holland</surname><given-names>AE</given-names></name><name><surname>Lareau</surname><given-names>SC</given-names></name><name><surname>Man</surname><given-names>WD</given-names></name><name><surname>Pitta</surname><given-names>F</given-names></name><name><surname>Sewell</surname><given-names>L</given-names></name><name><surname>Raskin</surname><given-names>J</given-names></name><name><surname>Bourbeau</surname><given-names>J</given-names></name><name><surname>Crouch</surname><given-names>R</given-names></name><name><surname>Franssen</surname><given-names>FM</given-names></name><name><surname>Casaburi</surname><given-names>R</given-names></name><name><surname>Vercoulen</surname><given-names>JH</given-names></name><name><surname>Vogiatzis</surname><given-names>I</given-names></name><name><surname>Gosselink</surname><given-names>R</given-names></name><name><surname>Clini</surname><given-names>EM</given-names></name><name><surname>Effing</surname><given-names>TW</given-names></name><name><surname>Maltais</surname><given-names>F</given-names></name><name><surname>van der Palen</surname><given-names>J</given-names></name><name><surname>Troosters</surname><given-names>T</given-names></name><name><surname>Janssen</surname><given-names>DJ</given-names></name><name><surname>Collins</surname><given-names>E</given-names></name><name><surname>Garcia-Aymerich</surname><given-names>J</given-names></name><name><surname>Brooks</surname><given-names>D</given-names></name><name><surname>Fahy</surname><given-names>BF</given-names></name><etal/><article-title>An official american thoracic society/european respiratory society statement: key concepts and advances in pulmonary rehabilitation</article-title><source>Am J Respir Crit Care Med</source><year>2013</year><volume>188</volume><issue>8</issue><fpage>e13</fpage><lpage>e64</lpage><pub-id pub-id-type="doi">10.1164/rccm.201309-1634ST</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Hogg</surname><given-names>L</given-names></name><name><surname>Garrod</surname><given-names>R</given-names></name><name><surname>Thornton</surname><given-names>H</given-names></name><name><surname>McDonnell</surname><given-names>L</given-names></name><name><surname>Bellas</surname><given-names>H</given-names></name><name><surname>White</surname><given-names>P</given-names></name><article-title>Effectiveness, attendance, and completion of an integrated, system-wide pulmonary rehabilitation service for COPD: prospective observational study</article-title><source>Copd</source><year>2012</year><volume>9</volume><issue>5</issue><fpage>546</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.3109/15412555.2012.707258</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Probst</surname><given-names>VS</given-names></name><name><surname>Troosters</surname><given-names>T</given-names></name><name><surname>Pitta</surname><given-names>F</given-names></name><name><surname>Decramer</surname><given-names>M</given-names></name><name><surname>Gosselink</surname><given-names>R</given-names></name><article-title>Cardiopulmonary stress during exercise training in patients with COPD</article-title><source>Eur Respir J</source><year>2006</year><volume>27</volume><issue>6</issue><fpage>1110</fpage><lpage>1118</lpage><pub-id pub-id-type="doi">10.1183/09031936.06.00110605</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><collab>American College of Sports Medicine position stand</collab><article-title>Progression models in resistance training for healthy adults</article-title><source>Med Sci Sports Exerc</source><year>2009</year><volume>41</volume><issue>3</issue><fpage>687</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e3181915670</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Maffiuletti</surname><given-names>NA</given-names></name><article-title>Physiological and methodological considerations for the use of neuromuscular electrical stimulation</article-title><source>Eur J Appl Physiol</source><year>2010</year><volume>110</volume><issue>2</issue><fpage>223</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1007/s00421-010-1502-y</pub-id><pub-id pub-id-type="pmid">20473619</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Vanderthommen</surname><given-names>M</given-names></name><name><surname>Duchateau</surname><given-names>J</given-names></name><article-title>Electrical stimulation as a modality to improve performance of the neuromuscular system</article-title><source>Exerc Sport Sci Rev</source><year>2007</year><volume>35</volume><issue>4</issue><fpage>180</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1097/jes.0b013e318156e785</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Spruit</surname><given-names>MA</given-names></name><name><surname>Wouters</surname><given-names>EF</given-names></name><article-title>New modalities of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease</article-title><source>Sports Med</source><year>2007</year><volume>37</volume><issue>6</issue><fpage>501</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.2165/00007256-200737060-00004</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Sillen</surname><given-names>MJ</given-names></name><name><surname>Speksnijder</surname><given-names>CM</given-names></name><name><surname>Eterman</surname><given-names>RM</given-names></name><name><surname>Janssen</surname><given-names>PP</given-names></name><name><surname>Wagers</surname><given-names>SS</given-names></name><name><surname>Wouters</surname><given-names>EF</given-names></name><name><surname>Uszko-Lencer</surname><given-names>NH</given-names></name><name><surname>Spruit</surname><given-names>MA</given-names></name><article-title>Effects of neuromuscular electrical stimulation of muscles of ambulation in patients with chronic heart failure or COPD: a systematic review of the English-language literature</article-title><source>Chest</source><year>2009</year><volume>136</volume><issue>1</issue><fpage>44</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1378/chest.08-2481</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Sillen</surname><given-names>MJ</given-names></name><name><surname>Franssen</surname><given-names>FM</given-names></name><name><surname>Delbressine</surname><given-names>JM</given-names></name><name><surname>Vaes</surname><given-names>AW</given-names></name><name><surname>Wouters</surname><given-names>EF</given-names></name><name><surname>Spruit</surname><given-names>MA</given-names></name><article-title>Efficacy of lower-limb muscle training modalities in severely dyspnoeic individuals with COPD and quadriceps muscle weakness: results from the DICES trial</article-title><source>Thorax</source><year>2014</year><volume>69</volume><issue>6</issue><fpage>525</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2013-204388</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Sillen</surname><given-names>MJ</given-names></name><name><surname>Janssen</surname><given-names>PP</given-names></name><name><surname>Akkermans</surname><given-names>MA</given-names></name><name><surname>Wouters</surname><given-names>EF</given-names></name><name><surname>Spruit</surname><given-names>MA</given-names></name><article-title>The metabolic response during resistance training and neuromuscular electrical stimulation (NMES) in patients with COPD, a pilot study</article-title><source>Respir Med</source><year>2008</year><volume>102</volume><issue>5</issue><fpage>786</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2008.01.013</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Sillen</surname><given-names>MJ</given-names></name><name><surname>Wouters</surname><given-names>EF</given-names></name><name><surname>Franssen</surname><given-names>FM</given-names></name><name><surname>Meijer</surname><given-names>K</given-names></name><name><surname>Stakenborg</surname><given-names>KH</given-names></name><name><surname>Spruit</surname><given-names>MA</given-names></name><article-title>Oxygen uptake, ventilation, and symptoms during low-frequency versus high-frequency NMES in COPD: a pilot study</article-title><source>Lung</source><year>2011</year><volume>189</volume><issue>1</issue><fpage>21</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1007/s00408-010-9265-0</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Vivodtzev</surname><given-names>I</given-names></name><name><surname>Debigare</surname><given-names>R</given-names></name><name><surname>Gagnon</surname><given-names>P</given-names></name><name><surname>Mainguy</surname><given-names>V</given-names></name><name><surname>Saey</surname><given-names>D</given-names></name><name><surname>Dube</surname><given-names>A</given-names></name><name><surname>Pare</surname><given-names>ME</given-names></name><name><surname>Belanger</surname><given-names>M</given-names></name><name><surname>Maltais</surname><given-names>F</given-names></name><article-title>Functional and muscular effects of neuromuscular electrical stimulation in patients with severe COPD: a randomized clinical trial</article-title><source>Chest</source><year>2012</year><volume>141</volume><issue>3</issue><fpage>716</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1378/chest.11-0839</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Borges</surname><given-names>O</given-names></name><article-title>Isometric and isokinetic knee extension and flexion torque in men and women aged 20&#x02013;70</article-title><source>Scand J Rehabil Med</source><year>1989</year><volume>21</volume><issue>1</issue><fpage>45</fpage><lpage>53</lpage></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Spruit</surname><given-names>MA</given-names></name><name><surname>Gosselink</surname><given-names>R</given-names></name><name><surname>Troosters</surname><given-names>T</given-names></name><name><surname>De Paepe</surname><given-names>K</given-names></name><name><surname>Decramer</surname><given-names>M</given-names></name><article-title>Resistance versus endurance training in patients with COPD and peripheral muscle weakness</article-title><source>Eur Respir J</source><year>2002</year><volume>19</volume><issue>6</issue><fpage>1072</fpage><lpage>1078</lpage><pub-id pub-id-type="doi">10.1183/09031936.02.00287102</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Revill</surname><given-names>SI</given-names></name><name><surname>Robinson</surname><given-names>JO</given-names></name><name><surname>Rosen</surname><given-names>M</given-names></name><name><surname>Hogg</surname><given-names>MI</given-names></name><article-title>The reliability of a linear analogue for evaluating pain</article-title><source>Anaesthesia</source><year>1976</year><volume>31</volume><issue>9</issue><fpage>1191</fpage><lpage>1198</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2044.1976.tb11971.x</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Wegmann</surname><given-names>H</given-names></name><article-title>The &#x0201c;new&#x0201d; Declaration of Helsinki</article-title><source>J Int Biotechnol Law</source><year>2009</year><volume>6</volume><issue>4</issue><fpage>173</fpage><lpage>176</lpage></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Sillen</surname><given-names>MJ</given-names></name><name><surname>Franssen</surname><given-names>FM</given-names></name><name><surname>Delbressine</surname><given-names>JM</given-names></name><name><surname>Uszko-Lencer</surname><given-names>NH</given-names></name><name><surname>Vanfleteren</surname><given-names>LE</given-names></name><name><surname>Rutten</surname><given-names>EP</given-names></name><name><surname>Wouters</surname><given-names>EF</given-names></name><name><surname>Spruit</surname><given-names>MA</given-names></name><article-title>Heterogeneity in clinical characteristics and co-morbidities in dyspneic individuals with COPD GOLD D: findings of the DICES trial</article-title><source>Respir Med</source><year>2013</year><volume>107</volume><issue>8</issue><fpage>1186</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2013.04.020</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="other"><name><surname>Sillen</surname><given-names>MJ</given-names></name><name><surname>Franssen</surname><given-names>FM</given-names></name><name><surname>Delbressine</surname><given-names>JM</given-names></name><name><surname>Vaes</surname><given-names>AW</given-names></name><name><surname>Wouters</surname><given-names>EF</given-names></name><name><surname>Spruit</surname><given-names>MA</given-names></name><article-title>Efficacy of lower-limb muscle training modalities in severely dyspnoeic individuals with chronic obstructive pulmonary disease and quadriceps muscle weakness: results from the DICES trial</article-title><source>Thorax</source><year>2013</year><comment>in press</comment></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Hernandes</surname><given-names>NA</given-names></name><name><surname>Wouters</surname><given-names>EF</given-names></name><name><surname>Meijer</surname><given-names>K</given-names></name><name><surname>Annegarn</surname><given-names>J</given-names></name><name><surname>Pitta</surname><given-names>F</given-names></name><name><surname>Spruit</surname><given-names>MA</given-names></name><article-title>Reproducibility of 6-minute walking test in patients with COPD</article-title><source>Eur Respir J</source><year>2011</year><volume>38</volume><issue>2</issue><fpage>261</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1183/09031936.00142010</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Hul van &#x02019;t</surname><given-names>A</given-names></name><name><surname>Gosselink</surname><given-names>R</given-names></name><name><surname>Kwakkel</surname><given-names>G</given-names></name><article-title>Constant-load cycle endurance performance: test-retest reliability and validity in patients with COPD</article-title><source>J Cardiopulm Rehabil</source><year>2003</year><volume>23</volume><issue>2</issue><fpage>143</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1097/00008483-200303000-00012</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Theurel</surname><given-names>J</given-names></name><name><surname>Lepers</surname><given-names>R</given-names></name><name><surname>Pardon</surname><given-names>L</given-names></name><name><surname>Maffiuletti</surname><given-names>NA</given-names></name><article-title>Differences in cardiorespiratory and neuromuscular responses between voluntary and stimulated contractions of the quadriceps femoris muscle</article-title><source>Respir Physiol Neurobiol</source><year>2007</year><volume>157</volume><issue>2&#x02013;3</issue><fpage>341</fpage><lpage>347</lpage></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Giavedoni</surname><given-names>S</given-names></name><name><surname>Deans</surname><given-names>A</given-names></name><name><surname>McCaughey</surname><given-names>P</given-names></name><name><surname>Drost</surname><given-names>E</given-names></name><name><surname>MacNee</surname><given-names>W</given-names></name><name><surname>Rabinovich</surname><given-names>RA</given-names></name><article-title>Neuromuscular electrical stimulation prevents muscle function deterioration in exacerbated COPD: a pilot study</article-title><source>Respir Med</source><year>2012</year><volume>106</volume><issue>10</issue><fpage>1429</fpage><lpage>1434</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2012.05.005</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Abdellaoui</surname><given-names>A</given-names></name><name><surname>Prefaut</surname><given-names>C</given-names></name><name><surname>Gouzi</surname><given-names>F</given-names></name><name><surname>Couillard</surname><given-names>A</given-names></name><name><surname>Coisy-Quivy</surname><given-names>M</given-names></name><name><surname>Hugon</surname><given-names>G</given-names></name><name><surname>Molinari</surname><given-names>N</given-names></name><name><surname>Lafontaine</surname><given-names>T</given-names></name><name><surname>Jonquet</surname><given-names>O</given-names></name><name><surname>Laoudj-Chenivesse</surname><given-names>D</given-names></name><name><surname>Hayot</surname><given-names>M</given-names></name><article-title>Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot study</article-title><source>Eur Respir J</source><year>2011</year><volume>38</volume><issue>4</issue><fpage>781</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1183/09031936.00167110</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Troosters</surname><given-names>T</given-names></name><name><surname>Probst</surname><given-names>VS</given-names></name><name><surname>Crul</surname><given-names>T</given-names></name><name><surname>Pitta</surname><given-names>F</given-names></name><name><surname>Gayan-Ramirez</surname><given-names>G</given-names></name><name><surname>Decramer</surname><given-names>M</given-names></name><name><surname>Gosselink</surname><given-names>R</given-names></name><article-title>Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease</article-title><source>Am J Respir Crit Care Med</source><year>2010</year><volume>181</volume><issue>10</issue><fpage>1072</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1164/rccm.200908-1203OC</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Zanotti</surname><given-names>E</given-names></name><name><surname>Felicetti</surname><given-names>G</given-names></name><name><surname>Maini</surname><given-names>M</given-names></name><name><surname>Fracchia</surname><given-names>C</given-names></name><article-title>Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation</article-title><source>Chest</source><year>2003</year><volume>124</volume><issue>1</issue><fpage>292</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1378/chest.124.1.292</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Maffiuletti</surname><given-names>NA</given-names></name><name><surname>Roig</surname><given-names>M</given-names></name><name><surname>Karatzanos</surname><given-names>E</given-names></name><name><surname>Nanas</surname><given-names>S</given-names></name><article-title>Neuromuscular electrical stimulation for preventing skeletal-muscle weakness and wasting in critically ill patients: a systematic review</article-title><source>BMC Med</source><year>2013</year><volume>11</volume><fpage>137</fpage><pub-id pub-id-type="doi">10.1186/1741-7015-11-137</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Nuhr</surname><given-names>M</given-names></name><name><surname>Crevenna</surname><given-names>R</given-names></name><name><surname>Gohlsch</surname><given-names>B</given-names></name><name><surname>Bittner</surname><given-names>C</given-names></name><name><surname>Pleiner</surname><given-names>J</given-names></name><name><surname>Wiesinger</surname><given-names>G</given-names></name><name><surname>Fialka-Moser</surname><given-names>V</given-names></name><name><surname>Quittan</surname><given-names>M</given-names></name><name><surname>Pette</surname><given-names>D</given-names></name><article-title>Functional and biochemical properties of chronically stimulated human skeletal muscle</article-title><source>Eur J Appl Physiol</source><year>2003</year><volume>89</volume><issue>2</issue><fpage>202</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1007/s00421-003-0792-8</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Theriault</surname><given-names>R</given-names></name><name><surname>Boulay</surname><given-names>MR</given-names></name><name><surname>Theriault</surname><given-names>G</given-names></name><name><surname>Simoneau</surname><given-names>JA</given-names></name><article-title>Electrical stimulation-induced changes in performance and fiber type proportion of human knee extensor muscles</article-title><source>Eur J Appl Physiol Occup Physiol</source><year>1996</year><volume>74</volume><issue>4</issue><fpage>311</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1007/BF02226926</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Gondin</surname><given-names>J</given-names></name><name><surname>Brocca</surname><given-names>L</given-names></name><name><surname>Bellinzona</surname><given-names>E</given-names></name><name><surname>D&#x02019;Antona</surname><given-names>G</given-names></name><name><surname>Maffiuletti</surname><given-names>NA</given-names></name><name><surname>Miotti</surname><given-names>D</given-names></name><name><surname>Pellegrino</surname><given-names>MA</given-names></name><name><surname>Bottinelli</surname><given-names>R</given-names></name><article-title>Neuromuscular electrical stimulation training induces atypical adaptations of the human skeletal muscle phenotype: a functional and proteomic analysis</article-title><source>J Appl Physiol</source><year>2011</year><volume>110</volume><issue>2</issue><fpage>433</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00914.2010</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Perez</surname><given-names>M</given-names></name><name><surname>Lucia</surname><given-names>A</given-names></name><name><surname>Rivero</surname><given-names>JL</given-names></name><name><surname>Serrano</surname><given-names>AL</given-names></name><name><surname>Calbet</surname><given-names>JA</given-names></name><name><surname>Delgado</surname><given-names>MA</given-names></name><name><surname>Chicharro</surname><given-names>JL</given-names></name><article-title>Effects of transcutaneous short-term electrical stimulation on M. vastus lateralis characteristics of healthy young men</article-title><source>Pflugers Arch</source><year>2002</year><volume>443</volume><issue>5&#x02013;6</issue><fpage>866</fpage><lpage>874</lpage></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Tesch</surname><given-names>PA</given-names></name><name><surname>Thorsson</surname><given-names>A</given-names></name><name><surname>Essen-Gustavsson</surname><given-names>B</given-names></name><article-title>Enzyme activities of FT and ST muscle fibers in heavy-resistance trained athletes</article-title><source>J Appl Physiol</source><year>1989</year><volume>67</volume><issue>1</issue><fpage>83</fpage><lpage>87</lpage></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Kryger</surname><given-names>AI</given-names></name><name><surname>Andersen</surname><given-names>JL</given-names></name><article-title>Resistance training in the oldest old: consequences for muscle strength, fiber types, fiber size, and MHC isoforms</article-title><source>Scand J Med Sci Sports</source><year>2007</year><volume>17</volume><issue>4</issue><fpage>422</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0838.2006.00575.x</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Andersen</surname><given-names>JL</given-names></name><name><surname>Aagaard</surname><given-names>P</given-names></name><article-title>Myosin heavy chain IIX overshoot in human skeletal muscle</article-title><source>Muscle Nerve</source><year>2000</year><volume>23</volume><issue>7</issue><fpage>1095</fpage><lpage>1104</lpage><pub-id pub-id-type="doi">10.1002/1097-4598(200007)23:7&#x0003c;1095::AID-MUS13&#x0003e;3.0.CO;2-O</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Farup</surname><given-names>J</given-names></name><name><surname>Kjolhede</surname><given-names>T</given-names></name><name><surname>Sorensen</surname><given-names>H</given-names></name><name><surname>Dalgas</surname><given-names>U</given-names></name><name><surname>Moller</surname><given-names>AB</given-names></name><name><surname>Vestergaard</surname><given-names>PF</given-names></name><name><surname>Ringgaard</surname><given-names>S</given-names></name><name><surname>Bojsen-Moller</surname><given-names>J</given-names></name><name><surname>Vissing</surname><given-names>K</given-names></name><article-title>Muscle morphological and strength adaptations to endurance vs. resistance training</article-title><source>J Strength Cond Res</source><year>2012</year><volume>26</volume><issue>2</issue><fpage>398</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1519/JSC.0b013e318225a26f</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Verdijk</surname><given-names>LB</given-names></name><name><surname>Gleeson</surname><given-names>BG</given-names></name><name><surname>Jonkers</surname><given-names>RA</given-names></name><name><surname>Meijer</surname><given-names>K</given-names></name><name><surname>Savelberg</surname><given-names>HH</given-names></name><name><surname>Dendale</surname><given-names>P</given-names></name><name><surname>van Loon</surname><given-names>LJ</given-names></name><article-title>Skeletal muscle hypertrophy following resistance training is accompanied by a fiber type-specific increase in satellite cell content in elderly men</article-title><source>J Gerontol A Biol Sci Med Sci</source><year>2009</year><volume>64</volume><issue>3</issue><fpage>332</fpage><lpage>339</lpage></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="other"><name><surname>Sillen</surname><given-names>MJ</given-names></name><name><surname>Franssen</surname><given-names>FM</given-names></name><name><surname>Delbressine</surname><given-names>JM</given-names></name><name><surname>Vaes</surname><given-names>AW</given-names></name><name><surname>Wouters</surname><given-names>EF</given-names></name><name><surname>Spruit</surname><given-names>MA</given-names></name><article-title>Efficacy of lower-limb muscle training modalities in severely dyspnoeic individuals with COPD and quadriceps muscle weakness: response from the authors</article-title><source>Thorax</source><year>2014</year><comment>doi: 10.1136/thoraxjnl-2014-205781</comment></mixed-citation></ref></ref-list></back></article>